trolamine salicylate has been researched along with Armstrong Syndrome in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Auger, JL; Balfour, HH; Bilgic, H; Binstadt, BA; Bottini, N; Campbell, AM; Chan, AC; Cheng, G; Corbett, JA; Curtsinger, JM; Hasegawa, K; Ley, K; Mescher, MF; Mikulski, Z; Peterson, EJ; Sawatzke, K; Schmeling, DO; Shaheen, ZR; Shaked, I; Shoyama, FM; Stanford, SM; Wang, Y; Zhou, W | 1 |
1 other study(ies) available for trolamine salicylate and Armstrong Syndrome
| Article | Year |
|---|---|
The autoimmunity-associated gene PTPN22 potentiates toll-like receptor-driven, type 1 interferon-dependent immunity.
Topics: Animals; Arthritis; Autoimmunity; Cell Line; Cells, Cultured; Colitis; Dextran Sulfate; HEK293 Cells; Host-Pathogen Interactions; Humans; Immunity; Immunoblotting; Interferon Type I; Lymphocytic Choriomeningitis; Lymphocytic choriomeningitis virus; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Myeloid Cells; Protein Tyrosine Phosphatase, Non-Receptor Type 22; Reverse Transcriptase Polymerase Chain Reaction; TNF Receptor-Associated Factor 3; Toll-Like Receptors; Ubiquitination | 2013 |